Although we did not document M2 polarization of TAMs in our model, our results could be consistent with models in which CCL2 expression drives M2 polarization of TAMs in melanoma xenografts [42] and in human peripheral blood mononuclear cells [43]. The gene discussed is CCL2; the disease is melanoma.